MedPath

DeramsilkRx Anodynexa Pak

Approved
Approval ID

1b49b08b-8494-3f71-e054-00144ff88e88

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 13, 2015

Manufacturers
FDA

Patchwerx Labs, Inc.

DUNS: 079584480

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

diclofenac sodium delayed release tablets, ranitidine tablets, capsaicin cream

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69329-310
Application NumberANDA074514
Product Classification
M
Marketing Category
C73584
G
Generic Name
diclofenac sodium delayed release tablets, ranitidine tablets, capsaicin cream
Product Specifications
Effective DateJuly 13, 2015
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DeramsilkRx Anodynexa Pak - FDA Drug Approval Details